Sign up
Pharma Capital

Calum Muirhead

Junior Journalist

Calum graduated from the London School of Economics with an LLB (Hons) degree in Law in 2015. After brief stints in corporate insurance brokerage in Hong Kong and as a financial consultant associate in London, he joined a video game news site as a voluntary contributor. He was also the lead writer for a boutique travel startup. Following this, Calum joined Proactive in February 2018.


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.